923 results on '"CORNEC, DIVI"'
Search Results
2. [18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
3. Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures
4. Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis
5. Mapping the ocular surface from monocular videos with an application to dry eye disease grading
6. Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow
7. High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome
8. Phenotypic, transcriptomic, and spatial characterization of CD45RB+ naïve mature B cells: Implications in Sjögren's disease
9. Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus
10. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
11. Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group
12. The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
13. Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
14. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
15. Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis
16. French national diagnostic and care protocol for Sjögren's disease
17. Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: A retrospective cohort study
18. Comparison of halo and compression signs assessed by a high frequency ultrasound probe for the diagnosis of Giant Cell Arteritis
19. Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
20. Effets indésirables rhumatologiques des inhibiteurs de point de contrôle PD-(L)1 dans le cancer du poumon : revue systématique et méta-analyse
21. Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis
22. Inflammatory biomarkers associated with depression, anxiety, and/or fatigue in primary Sjögren's syndrome – a systematic review
23. BiomiX, a user-friendly bioinformatic tool for democratized analysis and integration of multiomics data.
24. Maladie de Sjögren : rare ou fréquent ?
25. Épidémiologie de l’atteinte dermatologique dans le syndrome de Sjögren : données provenant de trois populations françaises de Syndrome de Sjogren primitif (TEARS, ASSESS, diapSS)
26. The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
27. Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study
28. Artérite gigantocellulaire : expression cervico-céphalique
29. Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)
30. Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
31. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
32. Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
33. Tocilizumab controls bone turnover in early polymyalgia rheumatica
34. Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network
35. Temporal Artery Ultrasound to Diagnose Giant Cell Arteritis: A Practical Guide
36. Mapping the Ocular Surface from Monocular Videos with an Application to Dry Eye Disease Grading
37. A Genome‐Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome.
38. Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease.
39. The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle
40. Lung involvement in ANCA-associated vasculitis
41. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series
42. Évaluation de la taille des glandes salivaires majeures dans le syndrome de Gougerot-Sjögren primitif : comparaison de l’examen clinique et de l’échographie
43. Technique et valeur diagnostique de la biopsie de l’artère temporale
44. Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity
45. Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade
46. Salivary Glands and Periodontal Changes in a Population of Sjögren's and Sicca Syndrome Treated by Pilocarpine: A Pilot Study
47. The Sjögren's Working Group:The 2023 OMERACT meeting and provisional domain generation
48. The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
49. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
50. The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.